Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacturing and marketing of innovative health care products.

Get in touch with one of the Boehringer Ingelheim teams. We welcome your queries and feedback.

Learn more about Ridgefield, the home of Boehringer Ingelheim's US headquarters. The site serves as a key research center for human pharmaceuticals.

At Boehringer Ingelheim, we’re committed to addressing unmet medical needs for patients across the United States. Through this website, we provide comprehensive resources and support for medical professionals to access disease information, further innovative treatments, and advance medical research.

Discover Boehringer Ingelheim US Medical and Clinical Resources and explore information on our medical research, clinical developments, and clinical trials.

Learn about all of Boehringer Ingelheim's therapeutic products approved for use in the United States and their prescribing information.

Boehringer Ingelheim Animal Health has deep roots in the U.S. From a start in St. Joseph, Missouri, more than 100 years ago, we've grown to encompass seven sites, including our U.S. headquarters in Duluth, Georgia , plus research and manufacturing facilities in Georgia, Missouri, Iowa, New Jersey, and Puerto Rico.

More than 3,000 people power Boehringer Ingelheim Animal Health in the United States, focused on preventing disease and championing innovation. A part of a larger, family-owned company with a rich global history, Boehringer Ingelheim lives at …

Connect with a Boehringer Ingelheim sales representative in your area for information on our respiratory products. Designed for healthcare professionals

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity.

To report an adverse event to Boehringer Ingelheim, please call 1-800-542-6257 [TTY: 1-800-459-9906] Available 24/7. Submit Questions. To submit a medical information request or other medical inquiries to BI electronically, please visit https://www.bi-druginforequest.com.

Click to see a list of the Boehringer Ingelheim prescription medications that are available in the United States

Boehringer Ingelheim Pharmaceutical, Inc. (BIPI) Medical and Clinical Resources makes it simpler than ever for you to discover new medical research, explore the latest clinical developments, or get answers to medical queries.

Discover a world of opportunities at Boehringer Ingelheim. Join our team and contribute to improving human and animal health worldwide.

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacturing and marketing of innovative health care products.

More than 3,000 people power Boehringer Ingelheim Animal Health in the United States, focused on preventing disease and championing innovation. A part of a larger, family-owned company with a rich global history, Boehringer Ingelheim lives at …

Learn about the therapeutic areas Boehringer Ingelheim services for USA Health Care Providers (HCP)

To see where a career with Boehringer Ingelheim might take you, click on the countries below. We offer a wide range of career development opportunities in over 170 locations across the world. Take a look at some of our featured locations.

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacturing and marketing of innovative health care products.

The USA is one of our most successful and innovative regions. Explore career development opportunities in the USA or our 170 locations around the globe.

2025年1月22日 · In Boehringer Ingelheim v.Department of Health and Human Services, the United States Court of Appeals for the Second Circuit is considering whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional taking of drug manufacturers’ property.

Get in touch with Boehringer Ingelheim and access forms for general and medical information requests, product availability requests and product complaints.

2 天之前 · Boehringer Ingelheim announced today that the FIBRONEER™-ILD trial met its primary endpoint, which was the absolute change from baseline in FVC (mL) at week 52 versus placebo. FVC is a measure of lung function. 2 Initial data readouts of the FIBRONEER™-trials support a generally consistent safety and tolerability profile when compared to the Phase II …